197 related articles for article (PubMed ID: 11115689)
1. Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein.
Coëffier E; Clément JM; Cussac V; Khodaei-Boorane N; Jehanno M; Rojas M; Dridi A; Latour M; El Habib R; Barré-Sinoussi F; Hofnung M; Leclerc C
Vaccine; 2000 Nov; 19(7-8):684-93. PubMed ID: 11115689
[TBL] [Abstract][Full Text] [Related]
2. Expression of heterologous peptides at two permissive sites of the MalE protein: antigenicity and immunogenicity of foreign B-cell and T-cell epitopes.
Martineau P; Guillet JG; Leclerc C; Hofnung M
Gene; 1992 Apr; 113(1):35-46. PubMed ID: 1373395
[TBL] [Abstract][Full Text] [Related]
3. Modulating the immunological properties of a linear B-cell epitope by insertion into permissive sites of the MalE protein.
Martineau P; Leclerc C; Hofnung M
Mol Immunol; 1996 Dec; 33(17-18):1345-58. PubMed ID: 9171894
[TBL] [Abstract][Full Text] [Related]
4. Induction of T cell responses by chimeric bacterial proteins expressing several copies of a viral T cell epitope.
Lo-Man R; Martineau P; Hofnung M; Leclerc C
Eur J Immunol; 1993 Nov; 23(11):2998-3002. PubMed ID: 8223877
[TBL] [Abstract][Full Text] [Related]
5. The cellular location of a foreign B cell epitope expressed by recombinant bacteria determines its T cell-independent or T cell-dependent characteristics.
Leclerc C; Charbit A; Martineau P; Deriaud E; Hofnung M
J Immunol; 1991 Nov; 147(10):3545-52. PubMed ID: 1719080
[TBL] [Abstract][Full Text] [Related]
6. Molecular context of a viral T cell determinant within a chimeric bacterial protein alters the diversity of its T cell recognition.
Lo-Man R; Martineau P; Betton JM; Hofnung M; Leclerc C
J Immunol; 1994 Jun; 152(12):5660-9. PubMed ID: 7515911
[TBL] [Abstract][Full Text] [Related]
7. Expression and immunogenicity of the V3 loop from the envelope of human immunodeficiency virus type 1 in an attenuated aroA strain of Salmonella typhimurium upon genetic coupling to two Escherichia coli carrier proteins.
Charbit A; Martineau P; Ronco J; Leclerc C; Lo-Man R; Michel V; O'Callaghan D; Hofnung M
Vaccine; 1993 Sep; 11(12):1221-8. PubMed ID: 8256503
[TBL] [Abstract][Full Text] [Related]
8. Immune responses to hybrid maltose-binding proteins.
O'Callaghan D; Martineau P; Fayolle C; Leclerc C; Guillet JG; Charbit A; Hofnung M
Vaccine; 1993; 11(2):140-2. PubMed ID: 7679863
[TBL] [Abstract][Full Text] [Related]
9. ELNKWA-epitope specific antibodies induced by epitope-vaccine recognize ELDKWA- and other two neutralizing-resistant mutated epitopes on HIV-1 gp41.
Dong XN; Xiao Y; Chen YH
Immunol Lett; 2001 Jan; 75(2):149-52. PubMed ID: 11137140
[TBL] [Abstract][Full Text] [Related]
10. Epitope-vaccine induces high levels of ELDKWA-epitope-specific neutralizing antibody.
Xiao Y; Zhao Y; Lu Y; Chen YH
Immunol Invest; 2000 Feb; 29(1):41-50. PubMed ID: 10709845
[TBL] [Abstract][Full Text] [Related]
11. The neutralizing epitope ELDKWA on HIV-1 gp41: genetic variability and antigenicity.
Dong XN; Wu Y; Chen YH
Immunol Lett; 2005 Oct; 101(1):81-6. PubMed ID: 15951025
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of viral B- and T-cell epitopes expressed in recombinant bacterial proteins.
Leclerc C; Lo-Man R; Charbit A; Martineau P; Clément JM; Hofnung M
Int Rev Immunol; 1994; 11(2):123-32. PubMed ID: 7519229
[TBL] [Abstract][Full Text] [Related]
13. Structure-affinity relationships in the gp41 ELDKWA epitope for the HIV-1 neutralizing monoclonal antibody 2F5: effects of side-chain and backbone modifications and conformational constraints.
Tian Y; Ramesh CV; Ma X; Naqvi S; Patel T; Cenizal T; Tiscione M; Diaz K; Crea T; Arnold E; Arnold GF; Taylor JW
J Pept Res; 2002 Jun; 59(6):264-76. PubMed ID: 12010517
[TBL] [Abstract][Full Text] [Related]
14. A predefined epitope-specific monoclonal antibody recognizes ELDEWA-epitope just presenting on gp41 of HIV-1 O clade.
Huang J; Dong X; Liu Z; Qin L; Chen YH
Immunol Lett; 2002 Dec; 84(3):205-9. PubMed ID: 12413738
[TBL] [Abstract][Full Text] [Related]
15. The recombinant immunogen with high-density epitopes of ELDKWA and ELDEWA induced antibodies recognizing both epitopes on HIV-1 gp41.
Wang Z; Liu Z; Cheng X; Chen YH
Microbiol Immunol; 2005; 49(8):703-9. PubMed ID: 16113499
[TBL] [Abstract][Full Text] [Related]
16. Overcoming the crypticity of a viral T cell determinant by insertion into a chimeric bacterial protein.
Lo-Man R; Martineau P; Manoury-Schwartz B; Hofnung M; Leclerc C
Int Immunol; 1996 Aug; 8(8):1245-55. PubMed ID: 8918694
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Escherichia coli.
Bckström M; Holmgren J; Schödel F; Lebens M
Gene; 1995 Nov; 165(2):163-71. PubMed ID: 8522171
[TBL] [Abstract][Full Text] [Related]
18. Recombinant multi-epitope vaccine induce predefined epitope-specific antibodies against HIV-1.
Li H; Liu ZQ; Ding J; Chen YH
Immunol Lett; 2002 Nov; 84(2):153-7. PubMed ID: 12270553
[TBL] [Abstract][Full Text] [Related]
19. ELDKWA-epitope-specific monoclonal antibodies inhibit HIV env-mediated syncytium formation.
Zhang G; Chen YH
Immunobiology; 2003; 207(4):259-64. PubMed ID: 12952348
[TBL] [Abstract][Full Text] [Related]
20. Immunogenic presentation of a conserved gp41 epitope of human immunodeficiency virus type 1 on recombinant surface antigen of hepatitis B virus.
Eckhart L; Raffelsberger W; Ferko B; Klima A; Purtscher M; Katinger H; Rüker F
J Gen Virol; 1996 Sep; 77 ( Pt 9)():2001-8. PubMed ID: 8810996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
